Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
WINTER, William E, MAXWELL, G. Larry, CHUNQIAO TIAN, CARLSON, Jay W, OZOLS, Robert F, ROSE, Peter G, MARKMAN, Maurie, ARMSTRONG, Deborah K, MUGGIA, Franco, MCGUIRE, William P
Published in Journal of clinical oncology (20.08.2007)
Published in Journal of clinical oncology (20.08.2007)
Get full text
Journal Article
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
BOOKMAN, Michael A, BRADY, Mark F, MUTCH, David G, BURGER, Robert A, SWART, Ann Marie, TRIMBLE, Edward L, ACCARIO-WINSLOW, Chrisann, ROTH, Lawrence M, MCGUIRE, William P, HARPER, Peter G, ALBERTS, David S, FRIEDLANDER, Michael, COLOMBO, Nicoletta, FOWLER, Jeffrey M, ARGENTA, Peter A, DE GEEST, Koen
Published in Journal of clinical oncology (20.03.2009)
Published in Journal of clinical oncology (20.03.2009)
Get full text
Journal Article
Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
Fields, Emma C, McGuire, William P, Lin, Lilie, Temkin, Sarah M
Published in Frontiers in oncology (21.08.2017)
Published in Frontiers in oncology (21.08.2017)
Get full text
Journal Article
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
WINTER, William E, MAXWELL, G. Larry, CHUNQIAO TIAN, SUNDBORG, Michael J, ROSE, G. Scott, ROSE, Peter G, RUBIN, Stephen C, MUGGIA, Franco, MCGUIRE, William P
Published in Journal of clinical oncology (01.01.2008)
Published in Journal of clinical oncology (01.01.2008)
Get full text
Journal Article
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
Coleman, Robert L, Sill, Michael W, Thaker, Premal H, Bender, David P, Street, Daron, McGuire, William P, Johnston, Carolyn M, Rotmensch, Jacob
Published in Gynecologic oncology (01.07.2015)
Published in Gynecologic oncology (01.07.2015)
Get full text
Journal Article
Randomized phase II study of the PDGFRα antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
McGuire, William P, Penson, Richard T, Gore, Martin, Herraez, Antonio Casado, Peterson, Patrick, Shahir, Ashwin, Ilaria, Jr, Robert
Published in BMC cancer (27.12.2018)
Published in BMC cancer (27.12.2018)
Get full text
Journal Article
The afatinib resistance of in vivo generated H1975 lung cancer cell clones is mediated by SRC/ERBB3/c-KIT/c-MET compensatory survival signaling
Booth, Laurence, Roberts, Jane L, Tavallai, Mehrad, Webb, Timothy, Leon, Daniel, Chen, Jesse, McGuire, William P, Poklepovic, Andrew, Dent, Paul
Published in Oncotarget (12.04.2016)
Published in Oncotarget (12.04.2016)
Get full text
Journal Article
A phase II study of ramucirumab (IMC-1121B) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma
Penson, Richard T, Moore, Kathleen M, Fleming, Gini F, Braly, Patricia, Schimp, Veronica, Nguyen, Hoa, Matulonis, Ursula A, Banerjee, Susana, Haluska, Paul, Gore, Martin, Bodurka, Diane C, Hozak, Rebecca R, Joshi, Adarsh, Xu, Yihuan, Schwartz, Jonathan D, McGuire, William P
Published in Gynecologic oncology (01.09.2014)
Published in Gynecologic oncology (01.09.2014)
Get full text
Journal Article
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma
Gordon, Sarah W, McGuire, 3rd, William P, Shafer, Danielle A, Sterling, Richard K, Lee, Hannah M, Matherly, Scott C, Roberts, John D, Bose, Prithviraj, Tombes, Mary B, Shrader, E Ellen, Ryan, Alison A, Kmieciak, Maciej, Nguyen, Tri, Deng, Xiaoyan, Bandyopadhyay, Dipankar, Dent, Paul, Poklepovic, Andrew S
Published in American journal of clinical oncology (01.08.2019)
Published in American journal of clinical oncology (01.08.2019)
Get more information
Journal Article
Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study
Darcy, Kathleen M, Brady, William E, Blancato, Jan K, Dickson, Robert B, Hoskins, William J, McGuire, William P, Birrer, Michael J
Published in Gynecologic oncology (01.09.2009)
Published in Gynecologic oncology (01.09.2009)
Get full text
Journal Article
Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients
BAKER, Sharyn D, VAN SCHAIK, Ron H. N, MCGUIRE, William P, DAWKINS, Fitzroy, GELDERBLOM, Hans, VERWEIJ, Jaap, SPARREBOOM, Alex, RIVORY, Laurent P, TEN TIJE, Albert J, DINH, Kimberly, GRAVELAND, Wilfried J, SCHENK, Paul W, CHARLES, Kellie A, CLARKE, Stephen J, CARDUCCI, Michael A
Published in Clinical cancer research (15.12.2004)
Published in Clinical cancer research (15.12.2004)
Get full text
Journal Article
Co-occurring substance use disorder: The impact on treatment adherence in women with locally advanced cervical cancer
Rubinsak, Lisa A., Terplan, Mishka, Martin, Caitlin E., Fields, Emma C., McGuire, William P., Temkin, Sarah M.
Published in Gynecologic oncology reports (01.05.2019)
Published in Gynecologic oncology reports (01.05.2019)
Get full text
Journal Article
Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line
Teng, Pang-Ning, Bateman, Nicholas W., Wang, Guisong, Litzi, Tracy, Blanton, Brian E., Hood, Brian L., Conrads, Kelly A., Ao, Wei, Oliver, Kate E., Darcy, Kathleen M., McGuire, William P., Paz, Keren, Sidransky, David, Hamilton, Chad A., Maxwell, G. Larry, Conrads, Thomas P.
Published in Human cell : official journal of Human Cell Research Society (01.07.2017)
Published in Human cell : official journal of Human Cell Research Society (01.07.2017)
Get full text
Journal Article
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: A Gynecologic Oncology Group study
Farley, John, Fuchiuji, Sartoru, Darcy, Kathleen M, Tian, Chunqiao, Hoskins, William J, McGuire, William P, Hanjani, Parviz, Warshal, David, Greer, Benjamin E, Belinson, Jerome, Birrer, Michael J
Published in Gynecologic oncology (01.06.2009)
Published in Gynecologic oncology (01.06.2009)
Get full text
Journal Article
Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group
MOORE, David H, DONNELLY, James, MCGUIRE, William P, ALMADRONES, Lois, CELLA, David F, HERZOG, Thomas J, WAGGONER, Steven E
Published in Journal of clinical oncology (15.11.2003)
Published in Journal of clinical oncology (15.11.2003)
Get full text
Journal Article
A Randomized Phase II Trial of Epigenetic Priming with Guadecitabine and Carboplatin in Platinum-resistant, Recurrent Ovarian Cancer
Oza, Amit M, Matulonis, Ursula A, Alvarez Secord, Angeles, Nemunaitis, John, Roman, Lynda D, Blagden, Sarah P, Banerjee, Susana, McGuire, William P, Ghamande, Sharad, Birrer, Michael J, Fleming, Gini F, Markham, Merry Jennifer, Hirte, Hal W, Provencher, Diane M, Basu, Bristi, Kristeleit, Rebecca, Armstrong, Deborah K, Schwartz, Benjamin, Braly, Patricia, Hall, Geoff D, Nephew, Kenneth P, Jueliger, Simone, Oganesian, Aram, Naim, Sue, Hao, Yong, Keer, Harold, Azab, Mohammad, Matei, Daniela
Published in Clinical cancer research (01.03.2020)
Published in Clinical cancer research (01.03.2020)
Get full text
Journal Article
Randomized phase II study of the PDGFR[alpha] antibody olaratumab plus liposomal doxorubicin versus liposomal doxorubicin alone in patients with platinum-refractory or platinum-resistant advanced ovarian cancer
McGuire, William P, Penson, Richard T, Gore, Martin, Herraez, Antonio Casado, Peterson, Patrick, Shahir, Ashwin, Ilaria, Robert
Published in BMC cancer (27.12.2018)
Published in BMC cancer (27.12.2018)
Get full text
Journal Article